Correlation Between Silo Pharma and Nanobac Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Nanobac Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Nanobac Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Nanobac Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Silo Pharma and Nanobac Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Nanobac Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Nanobac Pharmaceuticals.

Diversification Opportunities for Silo Pharma and Nanobac Pharmaceuticals

0.0

Correlation Coefficient

Silo Pharma  Nanobac Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Silo and Nanobac is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Nanobac Pharmaceuticals Incorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanobac Pharmaceuticals and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Nanobac Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanobac Pharmaceuticals has no effect on the direction of Silo Pharma i.e., Silo Pharma and Nanobac Pharmaceuticals go up and down completely randomly.

Pair Corralation between Silo Pharma and Nanobac Pharmaceuticals

If you would invest  207.00  in Silo Pharma on December 1, 2024 and sell it today you would lose (71.00) from holding Silo Pharma or give up 34.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Silo Pharma  vs.  Nanobac Pharmaceuticals Incorp

Silo Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Silo Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal essential indicators, Silo Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Nanobac Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nanobac Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Nanobac Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Silo Pharma and Nanobac Pharmaceuticals

The main advantage of trading using opposite Silo Pharma and Nanobac Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Nanobac Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanobac Pharmaceuticals will offset losses from the drop in Nanobac Pharmaceuticals' long position.

The idea behind Silo Pharma and Nanobac Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.